Top 200 Drugs of 2008
CMS Denying Payments for Many Preventable Errors-August 2008
Nosocomial infections and hypoglycemia/hyperglycemia have been added to the agency's list of problems that should never occur and whose resolution will not be covered.
Tolerating Bad Behavior May Impact Health Facilities Accreditation-August 2008
Citing evidence that intimidating and disruptive behavior by health care professionals is preventable and adversely affects patient care, the Joint Commission is adding professionalism elements to its Leadership standard.
California Medicaid Cuts Blocked...For Now-July 2008
A federal appeals court has temporarily suspended 10% reductions in Medi-Cal reimbursements for medications that had forced pharmacists to take losses or stop serving Medicaid beneficiaries.
New Tool Keeps Kids on Track with Immunizations-July 2008
Additionally, 2 new combination vaccines could make following CDC's immunization recommendations easier by reducing the number of shots children must receive.
Patients' Needs Guide OTC Recommendations
Top 200 Prescription Drugs of 2007
With expansion in the generics market and fewer FDA drug approvals, growth in dollar sales for drugs was down in 2007, though the number of prescriptions dispensed increased slightly.
Payers Pushing Generic Drugs to Curb Costs
PBMs are realizing that encouraging the use of generic medications not only helps their patients save money, it helps them save as well.
Educating Patients to Choose Generics Could Improve Adherence
Teaching patients about the benefits of generic replacements for their branded medications is a major step to improved adherence and cost savings.
Some Overseas Patents Proving Hard to Win, Hold
Playing ball with foreign nations to obtain patent approval for much-needed medications can be more difficult when you're not the home team.
Patent Expirations Could Mean Biologics Competition
As patent expirations creep closer, blockbuster drugs face increasing competition, and the FDA faces increasing pressure.
Watch for Blockbuster Generics over Next Year
Leading medications for allergies, heart failure, insomnia, and osteoporosis have recently lost or will soon lose patent protection.
Pharmacists Ally with Physicians in
Caring for Patients
Mr. Lamb is a freelance pharmacy writer living in Virginia Beach,
Va, and president of Thorough Cursor Inc.
Ensuring Adequate Competition
a Concern with Generics Mergers
Mr. Lamb is a freelance pharmacy
writer living in Virginia Beach, Va, and
president of Thorough Cursor Inc.
Unintended Outcomes May Prompt PDMA Rule Changes
Mr. Lamb is a freelance pharmacy writer living in Virginia Beach, Va and president of Thorough Cursor Inc.
Generics Are Boon to Those on Medicaid, Bane to Pharmacists
Compulsory Licensing: A Necessary Evil?
Top 200 Prescription Drugs of 2006
Cheaper Biologics May Soon Be a Reality
The Pros and Cons of Patent Settlements
Tysabri Is Back
Strategies and Tools for Promoting Medication Adherence
2 Clarke Drive Cranbury, NJ 08512